financetom
Business
financetom
/
Business
/
Nippon Steel emphasises its 'deep roots' in the US as it pursues U.S. Steel deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nippon Steel emphasises its 'deep roots' in the US as it pursues U.S. Steel deal
Mar 31, 2024 12:23 PM

TOKYO, April 1 (Reuters) - Nippon Steel ( NISTF ) intends

to pursue its proposed acquisition of U.S. Steel and wants

its "deep roots" in the United States to be recognised, its new

president said - remarks that come after U.S. President Joe

Biden expressed opposition to the deal.

The Japanese firm has agreed to buy U.S. Steel for roughly

$15 billion but the deal faces an uphill battle to approval in a

U.S. election year.

The White House sees steel as critical to national security

and Biden said last month that U.S. Steel should remain

domestically owned. His opponent in the November presidential

vote, former President Donald Trump, has promised to block the

deal if he is re-elected.

It's not clear if Biden plans to use any U.S regulatory

authorities to scuttle the deal.

"What U.S. politicians are concerned about is jobs and

whether U.S. Steel can develop as an iconic U.S. company in the

U.S.," Tadashi Imai told reporters last week before he took on

his new role on Monday.

"I am convinced that we're the most useful partner to help

U.S. Steel grow in the United States," he added.

Imai, 60, became president in a management reshuffle

intended to lower the average age of top executives but in a

break with tradition, its charismatic former president Eiji

Hashimoto has taken on the title of chief executive and will be

in charge of shepherding the acquisition.

The proposed deal has drawn strong criticism from some

lawmakers and the United Steelworkers (USW) labor union which is

worried about potential job losses.

Japan's largest steelmaker has pledged no job cuts as a

result of the deal, to honour all agreements between the union

and U.S. Steel as well as to move its own U.S. headquarters to

Pittsburgh where U.S. Steel is based.

Imai said he was hopeful that Nippon Steel ( NISTF ) would come to be

seen as a firm with deep roots in the U.S., noting that it has

had a presence there since the 1980s and has 4,000 employees in

the country, some of whom are also members of the USW.

"The most important thing and the only thing that we can do

is to talk to the USW in good faith," about investment plans and

measures to raise the competitiveness of U.S. Steel, he said.

Imai said that the acquisition would give U.S. Steel access

to Nippon Steel's ( NISTF ) advanced technologies such as electromagnetic

steel sheet, adding that the Japanese firm has some 2,000 steel

patents in North America while U.S. steelmakers in general had

roughly 200 each.

At home, Imai's main focus will be decarbonisation, he said,

adding that the company will soon need to make investment

decisions on whether to invest in new electric furnaces at two

sites - the Kyushu Works Yawata site in southern Japan and

Setouchi Works Hirohata site in western Japan.

The company must decide on the projects either this

financial year or the next one, Imai said.

"It will be a huge investment ... but the time for a key

decision is approaching on the technical certainty and

predictability of the return on investment."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nanobiotix Doses First Patient in Phase 2 Study of Lung Cancer Therapy
Nanobiotix Doses First Patient in Phase 2 Study of Lung Cancer Therapy
Jan 21, 2025
03:39 AM EST, 01/21/2025 (MT Newswires) -- Nanobiotix ( NBTX ) said Tuesday it dosed the first patient in a phase 2 trial testing the experimental drug, JNJ-1900, for stage 3 non-small cell lung cancer. The study is sponsored by Johnson & Johnson's ( JNJ ) subsidiary, Janssen Pharmaceutical, under a global licensing agreement. ...
Cognizant, CrowdStrike Partners to Enhance Enterprise Cybersecurity With AI-Powered Offerings
Cognizant, CrowdStrike Partners to Enhance Enterprise Cybersecurity With AI-Powered Offerings
Jan 21, 2025
03:56 AM EST, 01/21/2025 (MT Newswires) -- Cognizant Technology Solutions ( CTSH ) and CrowdStrike ( CRWD ) said Tuesday that they have partnered to transform enterprise security by delivering cybersecurity services powered by CrowdStrike's ( CRWD ) AI-driven Falcon platform. The companies said Cognizant would use the Falcon platform to help organizations streamline security operations, reduce complexity, and strengthen...
PicoCELA Closes $7 Million Initial Public Offering
PicoCELA Closes $7 Million Initial Public Offering
Jan 21, 2025
03:22 AM EST, 01/21/2025 (MT Newswires) -- PicoCELA ( PCLA ) said Monday it has closed its initial public offering of about 1.8 million American depositary shares at $4 per ADS for $7 million in gross proceeds to the company. The ADSs began trading on Nasdaq on Jan. 16 under the ticker symbol PCLA, the company said. ...
Davos- Banks running Trump
Davos- Banks running Trump "war rooms" as trade ructions expected
Jan 21, 2025
* Banks see immediate impact on trade, regulation from Trump * Trade flows to be disrupted, StanChart CEO says * Regulation has been stifling, BNY CEO says (Recasts, adds comments from JPMorgan ( JPM ) executive) By Lawrence White and Sinead Cruise LONDON, Jan 21 (Reuters) - Bankers at JPMorgan ( JPM ) worked through the night in a war...
Copyright 2023-2026 - www.financetom.com All Rights Reserved